Monster cells in malignant melanoma.
Sidhu
Harleen K
HK
Sidhu
Jagmohan S
JS
D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D002452:Cell Count; D026122:Factor XIIIa / Q000378:metabolism; D015726:Giant Cells / Q000473:pathology*; D006679:HIV Seropositivity / Q000150:complications; D018219:Histiocytoma, Benign Fibrous / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D006801:Humans; D007077:Ileal Diseases / Q000473:pathology* / Q000601:surgery; D007150:Immunohistochemistry; D007443:Intussusception / Q000473:pathology* / Q000601:surgery; D035002:Lower Extremity / Q000473:pathology / Q000601:surgery; D008198:Lymph Nodes / Q000033:anatomy & histology / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D008297:Male; D008543:Melanins / Q000378:metabolism; D008545:Melanoma / Q000175:diagnosis / Q000473:pathology*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis; D049268:Positron-Emission Tomography; D011859:Radiography; D012015:Reference Standards; D021701:Sentinel Lymph Node Biopsy; D009626:Terminology as Topic
D008543:Melanins; D009363:Neoplasm Proteins; D026122:Factor XIIIa